Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Bristol-Myers Squibb |
---|---|
Information provided by: | Bristol-Myers Squibb |
ClinicalTrials.gov Identifier: | NCT00002352 |
The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.
Condition | Intervention |
---|---|
Cytomegalovirus Infections HIV Infections |
Drug: Lobucavir |
Study Type: | Interventional |
Study Design: | Treatment, Dose Comparison, Safety Study |
Official Title: | Pilot Study of the Antiviral Activity of Multiple Doses of Oral Lobucavir in AIDS Patients |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Patients with the following prior conditions are excluded:
Prior Medication:
Excluded within 4 weeks prior to study entry:
Prior Treatment:
Excluded within 4 weeks prior to study entry:
United States, California | |
Mount Zion Med Ctr / UCSF | |
San Francisco, California, United States, 94115 | |
San Francisco Veterans Adm Med Cntr | |
San Francisco, California, United States, 94121 | |
United States, Minnesota | |
Univ of Minnesota | |
Minneapolis, Minnesota, United States, 55455 |
Study ID Numbers: | 248A, AI459-007 |
Study First Received: | November 2, 1999 |
Last Updated: | October 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00002352 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Cytomegalovirus Infections Acquired Immunodeficiency Syndrome Antiviral Agents |
Anti-Infective Agents Sexually Transmitted Diseases, Viral Anti-HIV Agents Lobucavir Acquired Immunodeficiency Syndrome Cytomegalovirus Antiviral Agents Immunologic Deficiency Syndromes Herpesviridae Infections |
Virus Diseases Anti-Retroviral Agents HIV Infections Sexually Transmitted Diseases Cytomegalic Inclusion Disease Cytomegalovirus Infections DNA Virus Infections Retroviridae Infections |
Communicable Diseases Anti-Infective Agents Sexually Transmitted Diseases, Viral Slow Virus Diseases Lobucavir Molecular Mechanisms of Pharmacological Action Infection Anti-Retroviral Agents Therapeutic Uses Cytomegalovirus Infections Retroviridae Infections RNA Virus Infections Anti-HIV Agents |
Immune System Diseases Acquired Immunodeficiency Syndrome Enzyme Inhibitors Antiviral Agents Immunologic Deficiency Syndromes Pharmacologic Actions Herpesviridae Infections Virus Diseases HIV Infections Sexually Transmitted Diseases Lentivirus Infections DNA Virus Infections |